Rifapentine plus isoniazid for latent tuberculosis infection in Brazil: a retrospective cohort study

被引：0
|
作者：
Chaves, Beatriz [1 ]
Souza, Ana Carolina [1 ]
Leung, Janaina [1 ]
Costa, Walter [1 ]
Santos, Ana Paula [1 ]
机构：
[1] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA1468
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
    Lai, Wendy A. A.
    Brethour, Kaitlyn
    D'Silva, Olivia
    Chaisson, Richard E. E.
    Zwerling, Alice A. A.
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [42] Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
    Wendy A. Lai
    Kaitlyn Brethour
    Olivia D’Silva
    Richard E. Chaisson
    Alice A. Zwerling
    BMC Public Health, 22
  • [43] One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
    Swindells, S.
    Ramchandani, R.
    Gupta, A.
    Benson, C. A.
    Leon-Cruz, J.
    Mwelase, N.
    Juste, M. A. Jean
    Lama, J. R.
    Valencia, J.
    Omoz-Oarhe, A.
    Supparatpinyo, K.
    Masheto, G.
    Mohapi, L.
    Escada, R. O. da Silva
    Mawlana, S.
    Banda, P.
    Severe, P.
    Hakim, J.
    Kanyama, C.
    Langat, D.
    Moran, L.
    Andersen, J.
    Fletcher, V.
    Nuermberger, E.
    Chaisson, R. E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (11): : 1001 - 1011
  • [44] AN INHALABLE RIFAPENTINE DRY POWDER TARGETING LATENT TUBERCULOSIS INFECTION
    Chan, John G. Y.
    Tyne, Anneliese S.
    Pang, Angel
    Duke, Colin
    Britton, Warwick J.
    Chan, Hak Kim
    Young, Paul M.
    Traini, Daniela
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2014, 27 (04) : A12 - A13
  • [45] Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection
    Hibma, Jennifer E.
    Radtke, Kendra K.
    Dorman, Susan E.
    Jindani, Amina
    Dooley, Kelly E.
    Weiner, Marc
    McIlleron, Helen M.
    Savic, Radojka M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (06) : 866 - 877
  • [46] Pharmacokinetics and safety of rifapentine in children: dosing for latent tuberculosis infection
    Liu, Weijian
    Xu, Nuo
    Li, Wei
    Mak, Wen Yao
    He, Tian
    Qin, Hongjuan
    Lu, Shuihua
    Lu, Hongzhou
    Xiang, Xiaoqiang
    Zhu, Xiao
    Zhang, Peize
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025,
  • [47] Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
    Borisov, Andrey S.
    Morris, Sapna Bamrah
    Njie, Gibril J.
    Winston, Carla A.
    Burton, Deron
    Goldberg, Stefan
    Woodruff, Rachel Yelk
    Allen, Leeanna
    LoBue, Philip
    Vernon, Andrew
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2018, 67 (25): : 723 - 726
  • [48] Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-Like Reactions During Treatment of Latent Tuberculosis Infection
    Moro, Ruth N.
    Mehaffy, Carolina
    De, Prithwiraj
    Phillips, Elizabeth
    Borisov, Andrey S.
    Sterling, Timothy R.
    Dobos, Karen M.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (05): : 1271 - 1278
  • [49] Severe hypertension after initiation of rifapentine/isoniazid for latent tuberculosis in renal transplant candidates
    Simkins, Jacques
    Morris, Michele I.
    Abbo, Lilian M.
    Camargo, Jose F.
    TRANSPLANT INTERNATIONAL, 2017, 30 (01) : 108 - 109
  • [50] The prevent TB study (TB trials consortium study 26): 3 months of once-weekly rifapentine plus isoniazid vs. 9 months of daily isoniazid for treatment of latent M. tuberculosis infection
    Sterling, T.
    Cayla, J.
    Miro, J.
    Villarino, E.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 63 - 63
12345